Advances in treating solid tumors

James Larkin speaks to Laura McGuiness, Managing Commissioning Editor: Dr James Larkin, FRCP, PhD, is a Consultant Medical Oncologist specializing in the treatment of patients with cancer of the kidney and cancers of the skin, including melanoma.

His research interests include the individualization of patient treatment in renal cancer and melanoma, the identification of mechanisms of sensitivity and resistance to systemic therapies and the combination of novel targeted therapies to treat these diseases.

Larkin received a first in Natural Sciences from Cambridge University and undertook clinical training at Oxford University, qualifying in 1996. He underwent general medical training in London and in 2001 won a Medical Research Council Fellowship for a Clinician, carrying out laboratory research at The Institute of Cancer Research. He completed specialist training at The Royal Marsden and was appointed a Consultant in 2008.

He is UK Chief Investigator for a number of clinical trials in melanoma and kidney cancer and has been awarded research grants from bodies including Cancer Research UK and the 7th European Framework Programme and the Wellcome Trust.

Click here to view full article.